Gene · 406902
Papers3,238
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,238
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MicroRNAs Regulate Function in Atherosclerosis and Clinical Implications. | Oxid Med Cell Longev | 2023 | 37675243 | PubTator, text mining | PubMed |
| Molecular immune monitoring in kidney transplant rejection: a state-of-the-art review. | Front Immunol | 2023 | 37675106 | PubTator, text mining | PubMed |
| Exosomal miR-222-3p contributes to castration-resistant prostate cancer by activating mTOR signaling. | Cancer Sci | 2023 | 37671589 | PubTator, text mining | PubMed |
| Extracellular vesicle biomarkers in circulation for the diagnosis of gastric cancer: A systematic review and meta‑analysis. | Oncol Lett | 2023 | 37664665 | PubTator, text mining | PubMed |
| Dysregulated microRNAs as a biomarker for diagnosis and prognosis of hepatitis B virus-associated hepatocellular carcinoma. | World J Gastroenterol | 2023 | 37664153 | PubTator, text mining | PubMed |
| The dysregulation of miRNAs in epilepsy and their regulatory role in inflammation and apoptosis. | Funct Integr Genomics | 2023 | 37653173 | PubTator, text mining | PubMed |
| Exosomes are involved in the intercellular transfer of rapamycin resistance in the breast cancer cells. | Bioimpacts | 2023 | 37645026 | PubTator, text mining | PubMed |
| Diagnostic significance of dysregulated miRNAs in T-cell malignancies and their metabolic roles. | Front Oncol | 2023 | 37637043 | PubTator, text mining | PubMed |
| The Role of microRNAs in Epigenetic Regulation of Signaling Pathways in Neurological Pathologies. | Int J Mol Sci | 2023 | 37629078 | PubTator, text mining | PubMed |
| Circulating Tumour Cell Associated MicroRNA Profiles Change during Chemoradiation and Are Predictive of Response in Locally Advanced Rectal Cancer. | Cancers (Basel) | 2023 | 37627212 | PubTator, text mining | PubMed |
| ER Negative Breast Cancer and miRNA: There Is More to Decipher Than What the Pathologist Can See! | Biomedicines | 2023 | 37626796 | PubTator, text mining | PubMed |
| Micro- and Macrovascular Effects of Inflammation in Peripheral Artery Disease-Pathophysiology and Translational Therapeutic Approaches. | Biomedicines | 2023 | 37626780 | PubTator, text mining | PubMed |
| Crosstalk between Long Non-Coding RNA and Spliceosomal microRNA as a Novel Biomarker for Cancer. | Noncoding RNA | 2023 | 37624034 | PubTator, text mining | PubMed |
| Research Progress on Nanomaterials for Tissue Engineering in Oral Diseases. | J Funct Biomater | 2023 | 37623649 | PubTator, text mining | PubMed |
| Transcriptomic analyses of ovarian clear-cell carcinoma with concurrent endometriosis. | Front Endocrinol (Lausanne) | 2023 | 37621654 | PubTator, text mining | PubMed |
| The potential of using non-coding RNAs in forensic science applications. | Forensic Sci Res | 2023 | 37621455 | PubTator, text mining | PubMed |
| Combining Serum miR-144-3p and miR-652-3p as Potential Biomarkers for the Early Diagnosis and Stratification of Acute Cellular Rejection in Heart Transplantation Patients. | Transplantation | 2023 | 37606906 | PubTator, text mining | PubMed |
| Knockdown of long noncoding RNA SAN rejuvenates aged adipose-derived stem cells via miR-143-3p/ADD3 axis. | Stem Cell Res Ther | 2023 | 37605290 | PubTator, text mining | PubMed |
| Exosomal miRNA-mediated intercellular communications and immunomodulatory effects in tumor microenvironments. | J Biomed Sci | 2023 | 37605155 | PubTator, text mining | PubMed |
| SDF-1 and NOTCH signaling in myogenic cell differentiation: the role of miRNA10a, 425, and 5100. | Stem Cell Res Ther | 2023 | 37582765 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406902/papers?page=10